Cargando…

Ultrasound-mediated drug-free theranostics for treatment of prostate cancer

RATIONALE: Lipid-shelled nanobubbles (NBs) can be visualized and activated using noninvasive ultrasound (US) stimulation, leading to significant bioeffects. We have previously shown that active targeting of NBs to prostate-specific membrane antigen (PSMA) overexpressed in prostate cancer (PCa) enhan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perera, Reshani Himashika, Berg, Felipe Matias, Abenojar, Eric Chua, Nittayacharn, Pinunta, Kim, Youjoung, Wang, Xinning, Basilion, James P., Exner, Agata A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515807/ https://www.ncbi.nlm.nih.gov/pubmed/37745586 http://dx.doi.org/10.1101/2023.09.13.555594

Ejemplares similares

Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro
por: Perera, Reshani H., et al.
Publicado: (2022)

Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021)

Increasing Doxorubicin Loading in Lipid-Shelled Perfluoropropane Nanobubbles via a Simple Deprotonation Strategy
por: Nittayacharn, Pinunta, et al.
Publicado: (2020)

Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles
por: Nittayacharn, Pinunta, et al.
Publicado: (2023)

Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents
por: Johansen, Mette L., et al.
Publicado: (2021)

Sink or float? Characterization of shell-stabilized bulk nanobubbles using a resonant mass measurement technique
por: Hernandez, Christopher, et al.
Publicado: (2019)

The unique second wave phenomenon in contrast enhanced ultrasound imaging with nanobubbles
por: Chen, Chuan, et al.
Publicado: (2022)

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer
por: Wang, Xinning, et al.
Publicado: (2022)

Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity
por: Walker, Ethan, et al.
Publicado: (2022)

Characterization of the interaction of nanobubble ultrasound contrast agents with human blood components
por: Cooley, Michaela B., et al.
Publicado: (2022)

Theoretical and Experimental Gas Volume Quantification of Micro- and Nanobubble Ultrasound Contrast Agents
por: Abenojar, Eric C., et al.
Publicado: (2020)

Effects of shell-integrated Sudan Black dye on the acoustic activity and ultrasound imaging properties of lipid-shelled nanoscale ultrasound contrast agents
por: Wegierak, Dana, et al.
Publicado: (2022)

Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
por: Luo, Dong, et al.
Publicado: (2019)

Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors
por: Pellow, Carly, et al.
Publicado: (2020)

Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis in mouse models of type1 diabetes
por: Ramirez, David G., et al.
Publicado: (2020)

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
por: Wang, Xinning, et al.
Publicado: (2021)

Magnetic mediators for ultrasound theranostics
por: Józefczak, Arkadiusz, et al.
Publicado: (2021)

Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
por: Exner, Agata A., et al.
Publicado: (2022)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis
por: Luo, Dong, et al.
Publicado: (2021)

Exosomes and ultrasound: The future of theranostic applications
por: Sridharan, Badrinathan, et al.
Publicado: (2023)

GCP III is not the “off-target” for urea-based PSMA ligands
por: Lee, Zhenghong, et al.
Publicado: (2023)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Advanced nanomaterial for prostate cancer theranostics
por: Hao, Bin, et al.
Publicado: (2022)

Theranostic Oxygen Delivery Using Ultrasound and Microbubbles
por: Kwan, James J., et al.
Publicado: (2012)

Toward Precisely Controllable Acoustic Response of Shell-Stabilized Nanobubbles: High Yield and Narrow Dispersity
por: Jafari Sojahrood, Amin, et al.
Publicado: (2021)

CEST theranostics: label-free MR imaging of anticancer drugs
por: Li, Yuguo, et al.
Publicado: (2016)

Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2011)

PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022)

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
por: Fu, Lei, et al.
Publicado: (2016)

Retraction of “Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer”
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2017)

Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers
por: Calatayud, David G., et al.
Publicado: (2022)

Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics
por: Laudicella, Riccardo, et al.
Publicado: (2023)

The current status of prostate cancer treatment and PSMA theranostics
por: Uemura, Motohide, et al.
Publicado: (2023)

Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics
por: Min, Hyun Su, et al.
Publicado: (2015)

Theranostics in the vasculature: bioeffects of ultrasound and microbubbles to induce vascular shutdown
por: Padilla, Frederic, et al.
Publicado: (2023)

Concurrent Osteosarcoma Theranostic Strategy Using Contrast-Enhanced Ultrasound and Drug-Loaded Bubbles
por: Kuo, Tai-Tzung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m6kpeaqopsdlq4chjva3r5ilru